Liam Campion

2.9k total citations · 1 hit paper
9 papers, 2.2k citations indexed

About

Liam Campion is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Liam Campion has authored 9 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Immunology and 1 paper in Molecular Biology. Recurrent topics in Liam Campion's work include CAR-T cell therapy research (4 papers), Chemokine receptors and signaling (3 papers) and Immunotherapy and Immune Responses (2 papers). Liam Campion is often cited by papers focused on CAR-T cell therapy research (4 papers), Chemokine receptors and signaling (3 papers) and Immunotherapy and Immune Responses (2 papers). Liam Campion collaborates with scholars based in United States. Liam Campion's co-authors include Hui Zhang, Jeffrey W. Pollard, Linda A. Snyder, Jiufeng Li, Takanori Kitamura, Jinghang Zhang, Kathryn Packman, Melissa Smith, Shefali Patel and Gilles Bignan and has published in prestigious journals such as Nature, Blood and Cancer Research.

In The Last Decade

Liam Campion

9 papers receiving 2.2k citations

Hit Papers

CCL2 recruits inflammatory monocytes to facilitate breast... 2011 2026 2016 2021 2011 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liam Campion United States 4 1.5k 1.2k 748 311 194 9 2.2k
Cheei‐Sing Hau Netherlands 12 1.3k 0.9× 1.2k 1.0× 616 0.8× 282 0.9× 138 0.7× 15 2.2k
Christopher Groth Germany 14 1.5k 1.0× 1.1k 0.9× 584 0.8× 240 0.8× 176 0.9× 18 2.1k
Evgenii N. Tcyganov United States 6 1.5k 1.0× 947 0.8× 509 0.7× 239 0.8× 158 0.8× 7 2.0k
Nesrine I. Affara United States 12 1.4k 1.0× 1.2k 1.1× 681 0.9× 420 1.4× 103 0.5× 14 2.3k
Daniel W. Beury United States 9 1.2k 0.8× 853 0.7× 480 0.6× 199 0.6× 135 0.7× 10 1.8k
Eva Van Overmeire Belgium 16 1.3k 0.9× 767 0.7× 582 0.8× 233 0.7× 135 0.7× 20 1.9k
Ela Elyada Israel 9 584 0.4× 1.4k 1.2× 1.1k 1.5× 573 1.8× 197 1.0× 13 2.3k
Yueyun Pan China 4 801 0.5× 508 0.4× 600 0.8× 260 0.8× 135 0.7× 5 1.4k

Countries citing papers authored by Liam Campion

Since Specialization
Citations

This map shows the geographic impact of Liam Campion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liam Campion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liam Campion more than expected).

Fields of papers citing papers by Liam Campion

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liam Campion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liam Campion. The network helps show where Liam Campion may publish in the future.

Co-authorship network of co-authors of Liam Campion

This figure shows the co-authorship network connecting the top 25 collaborators of Liam Campion. A scholar is included among the top collaborators of Liam Campion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liam Campion. Liam Campion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Chin, Diana, Andriana Lebid, Mark Mendonça, et al.. (2024). Natural Killer and Gamma Delta T Cells Derived from Engineered Induced Pluripotent Stem Cells Have Potent Preclinical Activity to Treat B Cell-Mediated Autoimmune Diseases. Blood. 144(Supplement 1). 3437–3437. 3 indexed citations
2.
Millar, Hillary J., David H. Walker, Liam Campion, et al.. (2024). Abstract 6802: CXCR4 transgene improves in vivo migration and efficacy of engineered iPSC-derived natural killer cells. Cancer Research. 84(6_Supplement). 6802–6802. 2 indexed citations
3.
Hall, Matthew S., et al.. (2023). Abstract 2914: iPSC-derived CAR-NK cell therapy: nominating clinical candidate clones through integrated multi-functional analysis. Cancer Research. 83(7_Supplement). 2914–2914. 1 indexed citations
4.
Campion, Liam, Katherine E. Santostefano, Toshinobu Nishimura, et al.. (2022). 262 Multiple targeting of solid tumors with iPSC-derived gamma delta CAR T cells in combination with therapeutic antibodies. Regular and Young Investigator Award Abstracts. A277–A277. 2 indexed citations
5.
Borges, Luís, Mark A. Wallet, Michael Naso, et al.. (2021). Development of Multi-Engineered iPSC-Derived CAR-NK Cells for the Treatment of B-Cell Malignancies. Blood. 138(Supplement 1). 1729–1729. 6 indexed citations
6.
Smith, Melissa, Diana Chin, Szeman Ruby Chan, et al.. (2020). Abstract 5567: In vivo administration of the STING agonist, JNJ-67544412, leads to complete regression of established murine subcutaneous tumors. Cancer Research. 80(16_Supplement). 5567–5567. 9 indexed citations
7.
Adalsteinsson, Viktor A., Narmin Tahirova, Naren Tallapragada, et al.. (2013). Single cells from human primary colorectal tumors exhibit polyfunctional heterogeneity in secretions of ELR plus CXC chemokines. ARCA (Università Ca' Foscari Venezia). 16 indexed citations
8.
Li, Jiufeng, Hui Zhang, Takanori Kitamura, et al.. (2011). CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 475(7355). 222–225. 2207 indexed citations breakdown →
9.
Campion, Liam, Laura Johns, F L McCabe, et al.. (2009). Neutralizing CCL2 Inhibits Breast Tumor Growth Via Impact on the Tumor/Stroma Microenvironment.. Cancer Research. 69(24_Supplement). 6095–6095. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026